interesting article!
From my reading, these are some of the highlights:
- Concepts development of TAVR during the 90s
- In 1999, a small startup Percutaneous Valve Technologies’ (PVT, NJ, USA) was finally formed to develop the TAVR prototypes
- In 2000, PVT started animal trial on sheep
- In April 2002, PVT performed the first in-human TAVR trial on a 57 y.o. Patient
- While undergoing further TAVR trials and development, Edwards Lifesciences Corporation (Irvine, CA, USA) acquired PVT in 2004 for $155 million. (https://www.google.com.au/amp/s/www.haaretz.com/amp/1.4788606). TAVR entered a new era.
- Forums
- ASX - By Stock
- AVR
- Why Admedus’ shift to aortic valve replacement is good news for patients under 65
Why Admedus’ shift to aortic valve replacement is good news for patients under 65, page-12
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$9.99 |
Change
-0.910(8.35%) |
Mkt cap ! $211.1M |
Open | High | Low | Value | Volume |
$10.50 | $10.79 | $9.30 | $1.477M | 149.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $9.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.99 | 1999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | 9.700 |
2 | 146 | 9.600 |
1 | 1050 | 9.500 |
1 | 1500 | 9.420 |
1 | 1050 | 9.400 |
Price($) | Vol. | No. |
---|---|---|
9.990 | 1999 | 1 |
10.000 | 493 | 1 |
10.300 | 1000 | 1 |
10.450 | 357 | 1 |
10.600 | 11800 | 1 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |